Prenetics Global's Q3 revenue jumps on IM8 brand growth
PRE•Prenetics Global's Q3 2026 revenue rose 228% year over year to $64.1 million, while IM8 revenue grew 266%. The company reaffirmed its FY2026 revenue guidance of $220 million-$230 million and raised its second-half adjusted EBITDA loss outlook to $30 million-$35 million.
1. Revenue growth
Prenetics Global reported Q3 2026 revenue of $64.1 million, up 228% year over year and above company guidance. IM8 revenue increased 266%, marking its seventh consecutive record quarter; September was its strongest month, with a $284 million annualized revenue run-rate.
2. Loss outlook
The adjusted EBITDA loss was $12.7 million, or 20% of revenue, compared with 39% in Q2. Prenetics reaffirmed FY2026 revenue guidance of $220 million-$230 million and IM8 revenue guidance of $215 million-$222 million, while raising its second-half adjusted EBITDA loss outlook to $30 million-$35 million from $8 million-$12 million.
3. Customer metrics
The company reaffirmed its expectation for FY2027 IM8 revenue of at least $400 million. Customers acquired in Q1 2025 returned about 4.1 times their acquisition cost in gross profit in under two years, and customer acquisition cost declined for a second consecutive quarter to approximately $285.




